EBITDA: Income before interest, taxes, depreciation and amortization.
Allarity Therapeutics, Inc. (ALLR) had EBITDA of $-3.02M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-2.73M |
|
-- |
|
-- |
|
$3.04M |
|
$-3.04M |
|
$0.30M |
|
$-2.73M |
|
$-2.73M |
|
$-2.73M |
|
$-2.73M |
|
$-2.73M |
|
$-2.73M |
|
$-3.04M |
|
|
EBITDA |
$-3.02M |
11.15M |
|
11.15M |
|
$-0.25 |
|
$-0.25 |
|
| Balance Sheet Financials | |
$29.42M |
|
$0.31M |
|
$0.31M |
|
$29.73M |
|
$11.06M |
|
-- |
|
-- |
|
$11.06M |
|
$18.67M |
|
$18.67M |
|
$18.67M |
|
17.02M |
|
| Cash Flow Statement Financials | |
$-2.69M |
|
-- |
|
$11.14M |
|
$19.53M |
|
$27.70M |
|
$8.17M |
|
$0.14M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.66 |
|
-- |
|
-- |
|
-- |
|
0.07 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.69M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-14.63% |
|
-14.63% |
|
-9.19% |
|
-14.63% |
|
$1.10 |
|
$-0.24 |
|
$-0.24 |
|